Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation-Reference-Cited by-同舟云学术

Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation

Published:2017-01-27 Issue:6 Volume:140 Page:1356-1363
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Dieter Sebastian M.¹²,Giessler Klara M.¹,Kriegsmann Mark³,Dubash Taronish D.¹,Möhrmann Lino¹,Schulz Erik R.¹,Siegl Christine¹,Weber Sarah¹,Strakerjahn Hendrik¹,Oberlack Ava¹,Heger Ulrike¹⁴,Gao Jianpeng¹,Hartinger Eva-Maria¹,Oppel Felix¹,Hoffmann Christopher M.¹,Ha Nati⁵,Brors Benedikt⁵,Lasitschka Felix³,Ulrich Alexis⁴,Strobel Oliver⁴,Schmidt Manfred¹²,von Kalle Christof¹²⁶,Schneider Martin⁴,Weichert Wilko³⁷⁸,Ehrenberg K. Roland¹⁹¹⁰,Glimm Hanno¹²,Ball Claudia R.¹

Affiliation:

1. Department of Translational Oncology; National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ); Heidelberg Germany

2. German Cancer Consortium (DKTK); Heidelberg Germany

3. Institute of Pathology, Heidelberg University Hospital; Heidelberg Germany

4. Department of Surgery; Heidelberg University Hospital; Heidelberg Germany

5. Department of Applied Bioinformatics; NCT Heidelberg and DKFZ; Heidelberg Germany

6. Heidelberg Center for Personalized Oncology; DKFZ-HIPO, DKFZ; Heidelberg Germany

7. Institute of Pathology, Technische Universität München (TUM); Munich Germany

8. DKTK; Munich Germany

9. Department of Medical Oncology; NCT Heidelberg, Heidelberg, Germany

10. Department of Internal Medicine VI; Heidelberg University Hospital; Heidelberg Germany

Funder

Deutsche Forschungsgemeinschaft

Baden-Württemberg Stiftung